Our data showed that 83% (73/88) of patients expressed a low level of AATK protein in tumor tissues (Fig. 4a, b), and that the differences in patient outcome were significant (p < 0.05) in terms of overall patient survival between the two groups. Here, AATK is linked to neoplasm.